Hyperliquid Strategies Inc. (PURR)
NASDAQ: PURR · Real-Time Price · USD
3.900
+0.200 (5.13%)
At close: Dec 3, 2025, 4:00 PM EST
4.080
+0.180 (4.62%)
Pre-market: Dec 4, 2025, 4:48 AM EST
5.13% (1D)
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | n/a |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 4,160,330 |
| Open | 4.250 |
| Previous Close | n/a |
| Day's Range | 3.330 - 4.650 |
| 52-Week Range | 3.330 - 4.650 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PURR
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York. [Read more]
Founded 2025
Country United States
Stock Exchange NASDAQ
Ticker Symbol PURR
News
Ex-Barclays CEO unpacks Hyperliquid: ‘The FUTURE of finance'
Hyperliquid Strategies Inc. chairman Bob Diamond and Hyperliquid Stategies Inc. CEO David Schamis comment on the future of Hyperliquid Strategies Inc. on ‘The Claman Countdown.'
11 hours ago - Fox Business
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wednesday, December 3 Under the Ticker “PURR” Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wedn...
Other symbols: SONN
1 day ago - GlobeNewsWire